Valeant raises offer for Salix Pharma to $173 per share
March 16, 2015 at 08:13 AM EDT
March 16 (Reuters) - Valeant Pharmaceuticals International Inc said it increased its offer for Salix Pharmaceuticals Inc to $173 per share, hoping to end a bidding war with Endo International Plc for the bowel drug maker.